Device Trial Radar · NCT05741723
OCS DCD Heart + CAP Continued Follow-Up
Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
276
Planned (sponsor's estimate)
Start
Nov 26, 2019
Primary completion
Oct 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- TransMedicsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 23, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.
Conditions
- Heart Transplant
Interventions
OCS HeartDevice
Transplanted with OCS preserved heart.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient survivalTime frame: 5 years post-transplant
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
University of California San Diago
La Jolla, California
19 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.